Medplus Health Services Limited has requested the National Stock Exchange of India Limited and BSE Limited to disregard an inadvertent filing of an investor presentation made on July 21, 2026. The company stated that the filing contained an unintended attachment due to an error. The correct investor presentation has since been submitted to both exchanges, and stakeholders are advised to refer to this subsequent filing.

The erroneous submissions were made on the evening of July 21, 2026. The filing on the National Stock Exchange of India Limited occurred at 19:42:39 PM, while the submission to BSE Limited was recorded at 19:43:07 PM. Both filings were made under the subject "Investor Presentation."

The company clarified that the original filing and its attachment should be ignored. The communication was addressed to the Listing Departments of both exchanges and signed by Shrenik Soni, Company Secretary & Compliance Officer of Medplus Health Services Limited.

Medplus Health Services reported a 21.8% year-on-year increase in revenue to ₹18,796 million for the quarter ended June 30, 2026 (Q1FY27). Despite the top-line growth, net profit after tax (PAT) declined by 21.7% to ₹331.7 million, impacted by margin contraction. The Board of Directors approved the unaudited standalone and consolidated financial results on July 21, 2026, along with significant capital expenditure plans totalling ₹1,550 million. Subsequently, the company submitted the audio recording of the earnings call held on July 22, 2026, with analysts and institutional investors to discuss these results.

Financial Performance

The revenue growth was primarily driven by the retail segment, which contributed ₹18,423.92 million. However, the gross margin contracted by 160 basis points year-on-year to 24.5%, attributed to a lower sales mix of private label products and lower margins realized in the franchisee business. The operating EBITDA margin fell to 3.5% from 4.7% in the prior year, while the EBITDA margin stood at 7.1% compared to 8.47% in the corresponding period of the previous year.

Segment Performance

The retail segment saw its operating EBITDA drop by 14.8% year-on-year to ₹588.1 million, with margins shrinking to 3.2%. Conversely, the diagnostics segment showed strong growth, with revenue rising 22.4% to ₹370.8 million and operating EBITDA increasing 59.5% to ₹65.9 million.

Strategic Updates

The Board approved a CAPEX plan of approximately ₹400 million for Optival Health Solutions Private Limited, a material subsidiary, to set up a Food Park including a Cold Press Oil Extraction Unit at Hyderabad. Additionally, the company approved an investment of approximately ₹1,150 million to establish a Concierge Health & Wellness Services Facility in Hyderabad, comprising capital expenditure of ₹900 million. The Board also appointed Mr. Shrenik Soni as Company Secretary and Compliance Officer effective July 21, 2026.